Tag: GlobeNewswire

PacBio Kinnex sequencing will generate full-length transcript data to help advance TychoBio’s drug discovery models

MENLO PARK, Calif. and PARIS, Oct. 06, 2026 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, and TychoBio, an AI drug discovery company, today announced a collaboration to generate full-length RNA data that TychoBio will use to train models for RNA therapy design. Under the terms of the agreement, TychoBio plans to use PacBio HiFi sequencing and Kinnex long-read RNA sequencing to generate data from more than 10,000 samples, building large-scale datasets linking the design of steric blocking antisense oligonucleotides (SBOs) to their effects across the transcriptome, with plans to expand the approach to siRNA and other RNA-targeting compounds.

TychoBio will test candidate RNA therapies and use PacBio sequencing to measure how each one changes the transcriptome across multiple cell types. Those results will become training data for models designed to predict which compounds are most likely to work, how long their effects may last, and where unintended effects may occur.

Training models for maximizing on-target efficacy and effect duration of SBOs requires an in-depth understanding of the interaction between SBOs and the cell’s transcriptome. By more fully characterizing the effect of SBOs in various cell lineages, TychoBio will unlock new insights into RNA regulation and SBOs mechanism of action, accelerating the development of safer and more efficient therapeutic designs.

“AI models are only as good as the data they are trained on. To effectively identify new rare disease treatments, we needed the highest quality biological data, which can only be generated using PacBio HiFi sequencing technology,” said Felix Raimundo, founder and CEO of TychoBio. “HiFi long read sequencing lets us see across full-length transcripts, including changes in isoforms and splicing of how the transcriptome is affected in rare diseases and which treatments could modify disease processes.” 

PacBio has partnered across the rare disease community to support the characterization, diagnosis and development of therapeutics to address the global burden of rare disease including through its global HiFiSolves Consortium, the n-Lorem Foundation and EspeRare, the GREGoR Consortium, Care4Rare Canada Consortium, the Genetic Alliance, Genomics England, and many academic collaborations. The company’s Kinnex products, alongside HiFi sequencing, enable screening of thousands of sequences in multiple cell lineages as well as the development of models of both efficacy and toxicity, which are critical to advance potential rare disease therapies out of the laboratory and into patient clinical trials.  

“Our work with TychoBio, like our collaboration with Basecamp Research, highlights the critical value that high-quality sequencing data plays in generating the foundational data that will power biological modeling in the AI ecosystem,” said Mark Van Oene, President and Chief Executive Officer of PacBio. “We believe that this critical work will enable the development of transformative therapies that ultimately improve the lives of patients with rare diseases and their families.” 

The collaboration puts HiFi data directly into the research workflow for designing RNA therapeutics for rare diseases.  

About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.  

PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.  

About TychoBio
TychoBio is a frontier biology company that designs RNA therapeutics. Our data-generation platform unlocks scaling laws for gene therapies. We are bringing in therapeutic abundance to previously ignored patient populations. For more information, please visit www.tychobio.ai and follow @tychobio_ai.

Forward-Looking Statements 
This press release may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements, including statements relating to the availability, uses, accuracy, advantages, quality or performance of, or benefits of using, or expected benefits of using, PacBio products or technologies, including in connection with the collaboration between PacBio and TychoBio; plans related to potential therapy development and design, acceleration of safer and more efficient therapeutic designs and development, dataset generation, types of data generated, sequencing at least 10,000 samples, expansion to other compounds, and impact on rare disease characterization and diagnosis; transforming long-read sequencing data into meaningful genomic insights; value of high-quality sequencing data in AI ecosystem biological modeling; HiFi data being directly in the workflow for RNA therapy design for rare diseases; and other future events. You should not place undue reliance on forward-looking statements because they are subject to assumptions, risks, and uncertainties and could cause actual outcomes and results to differ materially from currently anticipated results, including, challenges inherent in using new technologies; potential product performance and quality issues; rapidly changing technologies and extensive competition in, and potential FDA regulatory issues relating to, genomic sequencing; unanticipated increases in costs or expenses; interruptions or delays in the supply of components or materials for, or manufacturing of, PacBio products and products under development; third-party claims alleging infringement of patents and proprietary rights or seeking to invalidate PacBio’s patents or proprietary rights, among others. Additional factors that could materially affect actual results can be found in PacBio’s most recent filings with the Securities and Exchange Commission, including PacBio’s most recent reports on Forms 8-K, 10-K, and 10-Q, and include those listed under the caption “Risk Factors.” These forward-looking statements are based on current expectations and speak only as of the date hereof; except as required by law, PacBio disclaims any obligation to revise or update these forward-looking statements to reflect events or circumstances in the future, even if new information becomes available.
Contacts:

Investors: 
ir@pacb.com

Media: 
pr@pacb.com

Roth Capital’s recent Buy initiation adds to the Anticipation Surrounding Expected October FDA discussion and NeOnc’s scheduled November 17 meeting

DENVER, Oct. 06, 2026 (GLOBE NEWSWIRE) — (247marketnews.com) — A fall calendar is bringing NeOnc Technologies Holdings’ (NASDAQ: NTHI) investigational brain-cancer programs into focus.

Anticipation is building as Roth Capital’s recent Buy initiation adds another Wall Street voice to the NTHI story. With Roth anticipating an October FDA discussion for NEO100 and NeOnc’s November 17 meeting for NEO212 on the calendar, the coming weeks put the company’s clinical development plans firmly in the spotlight.

For traders following biotech milestones, NTHI offers a timely story to research: clinical findings, regulatory discussions and the potential next steps for two brain-cancer therapies.

October: Attention turns to NEO100

Jonathan Aschoff’s research indicate that he anticipates an FDA Type B end-of-Phase 2 meeting for NEO100 in October. The Roth Capital analyst also sees pivotal trials potentially beginning before year-end.

The anticipated discussion could help clarify the program’s next clinical steps, including the evidence and study design needed to advance development. For investors following NeOnc, that makes regulatory feedback a central part of the fall watchlist.

November 17: NEO212 takes its turn

NeOnc has announced an in-person FDA End-of-Phase 1 Type B meeting for NEO212 on November 17, 2026, about six weeks away.

The company plans to discuss its proposed patient population, trial design, endpoints, dose selection and evidence needed to support a future marketing application.

Together, the anticipated NEO100 discussion and scheduled NEO212 meeting create two opportunities for greater clarity on NeOnc’s development strategy this fall.

Brain-cancer research gives the calendar substance

In August, NeOnc reported that its NEO100 Phase 2a study met its primary endpoint. The company reported six-month progression-free survival of 48.9%, compared with a prespecified historical benchmark of 20%, and median overall survival of 26.09 months.

The results came from an open-label, 24-patient study of patients with recurrent or progressive IDH1-mutant high-grade glioma. The findings now form part of the evidence supporting the company’s pursuit of further clinical development.

NEO100 is administered intranasally and is designed to address drug-delivery challenges associated with treating cancers in the brain. Alongside it, NeOnc is advancing NEO212, an investigational oral therapy.

Orphan Drug, Fast Track and Rare Pediatric Disease designations

NeOnc reports that NEO100 holds FDA Orphan Drug, Fast Track and Rare Pediatric Disease designations.

These designations add to the program’s regulatory background as NeOnc works toward its next development milestones. The upcoming discussions could help define how the company builds on its clinical findings and advances its investigational therapies.

Wall Street’s coverage has expanded

Roth Capital’s September 24 Buy initiation followed earlier Buy initiations from Alliance Global Partners, Maxim Group and BTIG.

That expanding coverage gives investors several analyst perspectives on NeOnc’s programs, development strategy and commercial potential. Roth’s recent initiation adds a fresh assessment as the company enters its fall regulatory window.

The catalyst window is here

For traders building a biotech watchlist, NTHI brings together several developments’ worth following: two investigational therapies, reported clinical progress, multiple Buy initiations and regulatory discussions approaching in October and November.

The next chapter will unfold through FDA feedback, company updates and subsequent clinical plans. With November 17 just over six weeks away and Roth anticipating a separate discussion this month, NeOnc has a calendar investors can follow closely.

For further details, please click here for full NTHI report and here for full NTHI compensation disclosure and third-party-content policies.

About 24/7 Market News

In today’s fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you’re an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact sales@247mnn.com to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.

PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 24/7 is compensated by NTHI to provide ongoing news coverage of expected upcoming catalysts and events as well as market outreach services. For further disclosure information, please click here. This should not be construed as financial or investment advice. Trading involves substantial risk; consult your financial advisor.

Important Editorial Note: 247 highlights companies approaching significant catalysts and inflection points. This report reflects information available at the time of publication. Since developments can occur rapidly, readers should independently verify current information and review all company filings and disclosures.

CONTACT:
24/7 Market News
Editor@247mnn.com

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company’s ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company’s filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.

Almere, the Netherlands
October 6, 2026

ASM International N.V. (Euronext Amsterdam: ASM) will report its third quarter 2026 financial results at approximately 6:00 p.m. CET on Tuesday, October 27, 2026.

ASM will host the quarterly earnings conference call and webcast on Wednesday, October 28, 2026, at 3:00 p.m. CET.

Conference-call participants should pre-register using this link to receive the dial-in numbers, passcode and a personal PIN, which are required to access the conference call.

A simultaneous audio webcast and replay will be accessible at this link.

About ASM

ASM International N.V., headquartered in Almere, the Netherlands, and its subsidiaries design and manufacture equipment and process solutions to produce semiconductor devices for wafer processing, and have facilities in the United States, Europe, and Asia. ASM’s common stock trades on the Euronext Amsterdam Stock Exchange (symbol: ASM). For more information, visit ASM’s website at www.asm.com.

Contacts
Investor and media relations	Investor relations
Victor Bareño	Daniel Uribe
T: +31 88 100 8500	T: +31 88 100 8127
E: investor.relations@asm.com	E: investor.relations@asm.com

KALMAR CORPORATION, TRADE PRESS RELEASE, 6 OCTOBER 2026 AT 16:00 (EEST)

Kalmar announces proactive safety update for Ottawa T2 terminal tractors

On 5 October 2026, Kalmar issued a recall notice with the US National Highway Traffic Safety Administration (NHTSA). The recall applies to the Ottawa T2 4×2 DOT/EPA, Ottawa T2 Off Road, and Ottawa T2 6×4 DOT/EPA terminal tractor configurations. 

The power distribution board in the cabin can experience a breakdown of electrical insulation resistance and may also be subject to a short circuit and has, in very rare circumstances, led to thermal events. Units involved with these events account for a very small portion of the Ottawa T2 fleet—less than 0.001% of total units.  

While these instances are rare, Kalmar is taking proactive steps to address the issue and support the continued safety and reliability of the Ottawa T2 units. The recall will provide the addition of a remote ground stud (RGS/fuse) to completely isolate certain electrical circuits and prevent thermal events from occurring. 

Kalmar will notify customers directly in the upcoming weeks with further details on implementation of the RGS in the affected vehicles. The Kalmar service team will work directly with customers to coordinate scheduling, helping return their vehicles to service as promptly as possible.   

“Customer safety and the reliability of their operations are of utmost importance to us,” said Thor Brenden, President, Terminal Tractors, Kalmar. “We are taking direct action to reach affected owners, provide clear guidance and complete the necessary work. We will work closely with customers and our service network throughout this process to help keep their Ottawa T2 terminal tractor fleets productive.”

Further information for the press:
Cristina Murray, Director, Marketing & Communications
cristina.murray@kalmarglobal.com

Kalmar (Nasdaq Helsinki: KALMAR) is moving goods in critical supply chains around the world, with the vision to be the forerunner in sustainable material handling equipment and services. The company offers a wide range of industry shaping heavy material handling equipment and services to ports and terminals, distribution centres, manufacturing and heavy logistics. Headquartered in Helsinki, Finland, Kalmar operates globally in over 120 countries and employs approximately 5,300 people. In 2025, the company’s sales totalled approximately EUR 1.7 billion. www.kalmarglobal.com  

NORTHFIELD, Ill., Oct. 06, 2026 (GLOBE NEWSWIRE) — Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report third quarter 2026 financial results on Wednesday, November 4, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results.

Information about Medline’s financial results, including a link to the live webcast, will be available on the Events page of Medline’s Investor Relations website at ir.medline.com. A replay of the webcast will be available following the event through the same website.

About Medline
Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its broad product portfolio, resilient supply chain and leading clinical solutions, Medline helps healthcare providers improve their clinical, financial and operational outcomes. Headquartered in Northfield, Ill., the company employs more than 45,000 people worldwide and operates in more than 100 countries. To learn more about how Medline makes healthcare run better, visit www.medline.com.

Contacts
Investor Relations:
Karen King
Global Head of Investor Relations

Patrick Flaherty
Director, Investor Relations

(847) 247-7222
IR@medline.com

Media Relations:
Ben Fox
Vice President, Corporate Communications
(224) 327-9999
MedlineMediaRelations@medline.com

Source: Medline Inc.

• Duluth Trading best-selling products help shoppers find useful gifts for everyone on their list 
• Top rated gifts include underwear, durable workwear, gardening gear, outdoor apparel and practical gifts under $50
• Holiday gift shopping can be done at DuluthTrading.com and at its 60+ retail stores nationwide

MOUNT HOREB, Wis., Oct. 06, 2026 (GLOBE NEWSWIRE) — With the holiday shopping season ramping up, Duluth Trading Co. (Duluth), a leading brand in functional workwear and outdoor apparel, releases its top gift ideas for early shoppers based on customer reviews and ratings. With Buck Naked^® underwear that won’t ride up, Fire Hose^® work pants built for real work, the Heirloom Gardening® collection’s blend of functionality and favorite patterns, and the tuck-and-stay Longtail T^®, Duluth has become the go-to for hard-to-shop-for people and gifts that actually get used.

The proof is in the reviews: Best-selling holiday gifts
Duluth’s top gift ideas for early shoppers include favorite products with thousands of positive ratings and repeat purchases. The products are bestsellers for good reason: they solve everyday annoyances, and as gifts, they offer more than a festive holiday print. That’s what makes these thoughtful, useful gift picks for every practical person, outdoorsman, gardener, DIYer, and the one who “doesn’t want anything” on your holiday shopping list.

• Buck Naked^® underwear: the gift for anyone tired of underwear that rides up. One of Duluth Trading’s most-reviewed and most-gifted products, the quick-drying Men’s Buck Naked underwear has earned more than 30,000 five-star reviews, with the Performance Boxer Briefs rated roughly 4.8 out of 5 across more than 17,000 reviews. With no-ride-up and no-chafing, it’s the everyday essential people replace the least and complain about the most; the rare practical gift that earns a real “how did I not have this already.” Buck Naked underwear is available for men and women in gift-friendly multipacks and collectible prints.
• Fire Hose^® Work Pants: the gift for people who work with their hands. Rugged canvas with a Crouch Gusset™, an extra panel of fabric in the crotch for more room where it counts when kneeling or bending. For a mechanic, contractor, woodworker, or weekend warrior, Fire Hose is the gift they’ll wear until it wears out.
• Heirloom Gardening^® Bib Overalls: the gift for the four-season gardener. Beloved by vegetable gardeners, flower gardeners, homesteaders, landscapers and anyone who would rather spend Saturday in the garden than on the couch. Duluth debuted its best-selling Heirloom® Gardening Bib Overalls a decade ago, and gardeners quickly fell for the material, features and seasonal prints. The signature DuluthFlex^® ripstop construction offers a super-strong stretch and brush-clean finish, earning a 4.7-star rating from more than 3,800 online reviews.
• The Longtail T^® Shirt: the gift for anyone whose shirt won’t stay tucked. Cut three inches longer in the back, so it stays put no matter how much the wearer bends or reaches. The original problem-solver that launched Duluth’s apparel line. It’s an easy, universally appreciated gift across sizes and budgets.
• Tool organizers, garden accessories, and work bags: for the person always hunting for a tool. Duluth got its start in 1989 by inventing a new category of tool organizer, turning an ordinary bucket into a mobile workbench. This design aspect runs through today’s pocket-loaded bags, totes and organizers, creating ideal gifts for anyone who likes their gear close at hand and their workspace under control, whether in the garage or in the garden.

Duluth Trading gifts for the entire shopping list

• Best gifts for practical people: Duluth specializes in functional apparel, accessories and gear designed to solve real-world problems.
• Best gifts for gardeners: The Heirloom Gardening^® collection includes durable apparel and accessories designed for working outdoors.
• Best gifts for DIYers: Workwear, aprons, bags, tools and accessories are made for people who like to build, fix, tinker and get things done.
• Best gifts for men: Popular choices include Buck Naked^® underwear, Armachillo® cooling apparel, Fire Hose® work pants and everyday layers.
• Best gifts for women: Gift options range from gardening and workwear to comfortable everyday apparel and weather-ready layers.
• Best gifts under $50: Shoppers can find underwear, socks, accessories, apparel and useful gear at accessible price points.
• Best stocking stuffers: Small, useful gifts include underwear, socks, hats, gloves and everyday accessories.
• Best gifts for someone who has everything: Look for Duluth’s problem-solving products: the things they may not know they need until they have them.

Holiday Shopping FAQs

What are the best gifts from Duluth Trading?
Some of Duluth’s most giftable products include Buck Naked^® underwear, Fire Hose^® workwear, Heirloom Gardening^® apparel and gear, Armachillo^® cooling apparel, socks, accessories, and other functional everyday essentials. The best choice depends on the recipient’s interests, lifestyle and budget.

What are good Duluth Trading gifts for men?
Popular men’s gifts include Buck Naked^® underwear, Armachillo^® cooling apparel, Fire Hose^® work pants, shirts, socks and other everyday apparel and accessories. Duluth’s men’s gift assortment includes options for DIYers, outdoor enthusiasts, workers and men who value comfort and function.

What are good Duluth Trading gifts for women?
Duluth offers gifts for women across gardening, workwear, outdoor apparel and lifestyle clothing. Popular categories include Heirloom Gardening^®, No-Yank^® apparel, Armachillo^® cooling styles and functional everyday essentials.

What are good gifts for gardeners?
Good gifts for gardeners include durable gardening apparel, women’s bib overalls, garden pants, gloves, totes, sun protection and other gear designed for working outdoors. Duluth’s Heirloom Gardening^® collection for women is specifically designed with gardeners in mind.

What are good gifts for DIYers?
Practical gifts for DIYers include durable work pants, shirts, aprons, tool bags, organizers and other gear designed for people who build, repair, craft and work with their hands.

What are good stocking stuffers from Duluth Trading?
Duluth Trading stocking stuffers include underwear, socks, hats, gloves and other small accessories and everyday essentials.

Does Duluth Trading have gifts under $50?
Yes. Duluth Trading offers a selection of gifts under $50, including underwear, socks, accessories, apparel and smaller tools and gear.

What should I buy for someone who has everything?
Consider a practical, problem-solving gift they may not already own. Duluth Trading specializes in functional apparel, accessories and gear designed around everyday needs, making its products a useful option for hard-to-shop-for recipients.

Where can I buy Duluth Trading holiday gifts?
Customers can enjoy a one-stop shopping experience for holiday gifts at DuluthTrading.com, at more than 60 Duluth Trading retail stores nationwide or shop a curated collection of Duluth’s most popular items on Amazon. Find a Duluth Trading retail store near you: duluthtrading.com/find-stores/.

Media Contact
TURNER
duluth@turnerpr.com

TORONTO, Oct. 06, 2026 (GLOBE NEWSWIRE) — Cineplex Media and Amplified, the global authority in attention, released The Eye-Watering Cost of Dull Media – Canada Edition, a study examining how media environments in Canada shape advertising attention, brand outcomes and media efficiency.

The research conducted by Amplified estimates there is a $1.52 billion annual media-efficiency penalty associated with dull media in Canada. This is equivalent to approximately 25 cents of additional investment for every dollar spent in lower attention environments to achieve comparable advertising outcomes. Dull media refers to environments that generate low levels of active attention, where ads may be delivered or viewable, but receive little actual human attention.

The study measured 5,400 real ad views across cinema, Facebook and web using biometric attention measurement and modelled approximately 360,000 additional exposures across Instagram, YouTube, Snapchat, TikTok and Broadcast Video on Demand (BVOD), a form of connected TV viewing. Among directly measured environments, cinema generated the highest active attention, with 72% active attention and an average of 17.5 seconds of active viewing per exposure, compared with 3.2 seconds on Facebook and 0.3 seconds on web.

Key Findings

• Higher attention was associated with stronger brand outcomes. Cinema exposure was linked to stronger brand choice and memory associations compared to Facebook or web.
• Cinema can strengthen the impact of later digital advertising. Adding a prior cinema exposure improved the brand outcomes generated by subsequent web advertising versus web advertising alone.
• As attention declines, media efficiency declines with it. Amplified’s framework estimated media waste rose from 33% in non-dull/high-attention environments to 92% in extremely dull/low-attention environments.
• Challenger brands face a steeper penalty. Among brands studied, challenger brands showed an approximately four times faster decline in effectiveness than established brands as environments became lower attention.

The findings suggest not every impression creates an equal opportunity to influence consumers.

“This research gives advertisers a clearer view of how much attention different media environments actually generate,” said Kristie Painting, EVP & Managing Director, Cineplex Media. “While cinema’s performance is important, the broader opportunity is helping Canadian marketers look beyond delivery alone and consider the quality of exposure alongside traditional planning metrics.”

“The Canadian findings reinforce a fundamental point: a served impression and a seen impression are not the same thing,” said Dr. Karen Nelson-Field, Founder and CEO, Amplified. “Media environments create different amounts of human attention and those differences show up in brand outcomes and media efficiency. For marketers, the question is not simply how many impressions they can buy, but how much opportunity those impressions create to be seen and remembered.”

Methodology
Amplified measured 5,400 real ad views across cinema, Facebook and web among Canadian audiences using eye tracking and facial detection in natural viewing environments. Campaign creative was also modelled across Instagram, YouTube, Snapchat, TikTok and BVOD/Connected TV, generating approximately 360,000 additional modelled ad views. Attention was linked to two brand-response measures: Short-Term Advertising Strength (STAS), which compares immediate brand choice among exposed and unexposed audiences, and Mental Availability (MA), which measures brand associations tied to future buying situations. The full The Eye-Watering Cost of Dull Media – Canada Edition report is available at: https://www.amplified.co/resources/cost-of-dull-canada.

About Cineplex
Cineplex (TSX:CGX) is a top-tier Canadian brand that operates in the Film Entertainment and Content, Amusement and Leisure, and Media sectors. Cineplex offers a unique escape from the everyday to millions of guests through its circuit of 169 movie theatres and location-based entertainment venues. In addition to being Canada’s largest and most innovative film exhibitor, the company operates Canada’s favourite destination for ‘Eats & Entertainment’ (The Rec Room), complexes specially designed for teens and families (Playdium), and an entertainment concept that brings movies, amusement gaming, dining, and live performances together under one roof (Cineplex Junxion). It also operates successful businesses in cinema media (Cineplex Media), alternative programming (Cineplex Events) and motion picture distribution (Cineplex Pictures). Providing even more value for its guests, Cineplex is a partner in Scene+, Canada’s largest entertainment and lifestyle loyalty program.

Proudly recognized as having one of the country’s Most Admired Corporate Cultures, Cineplex employs over 10,000 people in its offices and venues across Canada. To learn more, visit Cineplex.com.

About Amplified
Amplified is the global authority in attention, helping the advertising industry move beyond proxy metrics to understand what people actually see, notice and engage with. Through live-environment research and predictive AI solutions, Amplified helps brands, agencies and media owners understand how creative and media are likely to perform before spend is committed. For more information, visit www.amplified.co.

Cineplex Media Relations:
PressRoom@Cineplex.com

Amplified Media Relations:
Clayton Parks: clayton@amplified.co

MOUNTAIN VIEW, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) — Kodiak AI, Inc. (“Kodiak”) (Nasdaq: KDK), a leading provider of Physical AI-powered autonomous driving technology, today reaffirmed that it remains firmly on track to launch unsupervised driverless long-haul commercial service by the end of 2026. The company’s Autonomy Readiness Measure (“ARM”) for long-haul driverless operations reached 96% at the end of September 2026, up from 93% at the end of August.

Kodiak has added five percentage points to its ARM in just two months, more than doubling its monthly rate of progress from earlier in the year.

Kodiak is now in the final stretch of completing its highway launch safety case in preparation of planned long-haul driverless launch in late 2026. Kodiak’s safety case is a structured argument, supported by evidence, that the Kodiak Driver, the company’s autonomous driving system, can operate safely in a defined operating environment.

Kodiak’s ARM measures the percentage of claims and evidence in Kodiak’s safety case for driverless operations that are materially complete. The increase to 96% reflects accelerated progress in the testing and validation activities required to launch the Kodiak Driver into long-haul driverless service, and operate that service safely and consistently with its commercial partners.

“We are on track to launch driverless long-haul service by the end of 2026, and our momentum is building,” said Don Burnette, founder and CEO, Kodiak. “September was our best month yet for closing safety case claims. We know exactly what we need to accomplish in the coming weeks to achieve driver-out long-haul operations, and have identified and scheduled the remaining engineering verification and validation activities. We expect to complete our long-haul safety case and launch long-haul driverless before year’s end. This launch will not be a one-time milestone. Our safety case is built to support ongoing driverless service our customers can rely on.”

Kodiak’s long-haul safety case builds on the safety case the company completed for its industrial deployment in the Permian Basin, where, as of the end of the second quarter of 2026, the company had deployed its technology in 35 unsupervised driverless trucks with no humans in the cab that are owned and operated by our customer, Atlas Energy Solutions. This deployment demonstrates the company’s unmatched operational expertise in commercial driverless trucking.

Kodiak’s progress toward closing its long-haul safety case has accelerated throughout 2026. The company reported an ARM of 84% as of February, 86% as of April, 91% as of July, and 93% as of August.

“This month’s progress came from finishing the hazard analyses for the systems that take over if something goes wrong, and from strengthening the evidence based on an adversarial review of our safety argument,” said Frank Fratrik, Director of Safety, Kodiak. “We continue to examine risks critically, even those that are highly unlikely to occur. The work still in front of us is well defined: completing the long-haul risk assessment with our Probabilistic Risk Assessment (PRA) methodology and Breakpoint simulation tool, verifying our launch vehicle configuration, and demonstrating how the truck can ensure safety at highway speeds.”

Forward Looking Statements

This press release includes forward-looking statements including regarding Kodiak’s or its management teams’ expectations, hopes, beliefs, intentions or strategies regarding the future. Forward-looking statements may be identified by the use of words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “forecast,” “intend,” “expect,” “may,” “plan,” “potential,” “project,” “seek,” “should,” “will,” “would” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, statements regarding: Kodiak’s expectations regarding the timing of launching driverless trucks for long-haul highways operations; Kodiak’s expectations regarding the timing of completion of work on its highway launch safety case; and Kodiak’s expectations with respect to its future performance and success. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of Kodiak’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied upon by any investors as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Kodiak. These forward-looking statements are subject to a number of risks and uncertainties, including changes in business, market, financial, political and legal conditions; the rapid evolution of autonomous vehicle technology and flaws or errors in Kodiak’s solutions or flaws in or misuse of autonomous vehicle technology in general; risks related to the rollout of Kodiak’s business and the timing of expected business milestones; the effects of competition on Kodiak’s business; supply shortages in the materials necessary for the production of the Kodiak Driver; risks related to working with third-party manufacturers for key components of the Kodiak Driver; risks related to the retrofitting of Kodiak’s vehicles by third parties; the termination or suspension of any of Kodiak’s contracts or the reduction in counterparty spending; delays in Kodiak’s operational roadmap with key partners and customers; and Kodiak’s ability to raise capital in the near term and long term. Additional information concerning these and other factors that may impact such forward-looking statements can be found in filings and potential filings by Kodiak with the Securities and Exchange Commission, including under the heading “Risk Factors.” If any of these risks materialize or any assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that Kodiak does not presently know, or that Kodiak currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements.

In addition, forward-looking statements reflect Kodiak’s expectations, plans or forecasts of future events and views as of the date they are made. Kodiak anticipates that subsequent events and developments will cause Kodiak’s assessments to change. However, while Kodiak may elect to update these forward-looking statements at some point in the future, Kodiak specifically disclaims any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing Kodiak’s assessments as of any date subsequent to the date they are made.

About Kodiak AI

Kodiak AI, Inc. (Nasdaq: KDK) is a leader in Physical AI, developing driverless technology that powers machines that move. The core of the company’s solution is the Kodiak Driver, a vehicle-agnostic autonomous driving system that combines advanced AI-powered software with modular hardware. Today, the Kodiak Driver operates in the long-haul trucking, industrial trucking, and defense sectors, and is already deployed in commercial operation with no one in the cab. Kodiak AI commercializes its technology through both a Driver-as-a-Service business model and strategic partnerships. In 2024, Kodiak achieved a historic milestone, becoming the first company to deploy driverless technology in customer-owned driverless semi-trucks. Commercial partners and customers include Atlas Energy Solutions, IKEA, Bridgestone, Werner Enterprises, C.R. England, General Dynamics Land Systems, and Roehl Transport.

For more information, visit kodiak.ai/investors. The Kodiak press kit, including videos and images, is available here.

Contacts

Kodiak Media Relations
Pete Bigelow
Public Relations Manager
pete.bigelow@kodiak.ai

Kodiak Investor Relations
Steve Philistin
Senior Investor Relations Manager
investors@kodiak.ai

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b5c353b6-99dd-4cf9-8a54-7bcb8da935aa.

Proposed Transaction Would Expand Vivakor’s Midstream Infrastructure and Environmental Services Platform in the Permian Basin

Dallas, TX, Oct. 06, 2026 (GLOBE NEWSWIRE) — Vivakor, Inc. (Nasdaq: VIVK) (“Vivakor” or the “Company”), an integrated provider of energy transportation, storage, reuse and remediation services, today announced that it has entered into a non-binding Indication of Interest (“IOI”) regarding the proposed acquisition of 100% of the outstanding membership interests of Direct Midstream, LLC (“Direct Midstream”), a Midland, Texas-based water midstream company providing produced water infrastructure and oilfield waste management services to oil and gas operators in the Permian Basin.

Direct Midstream currently operates seventeen saltwater disposal facilities and nine fresh water and brine stations, with approximately 11.5 million barrels per month of permitted disposal capacity. The company provides an integrated suite of services including Class II UIC saltwater disposal, fresh water and brine supply, oilfield waste management, oil reclamation and recovery, and slop oil processing. Direct Midstream’s facilities utilize automated monitoring technology to provide real-time operational data across its network.

The proposed acquisition would expand Vivakor’s presence in the Permian Basin and add produced water management and oilfield waste infrastructure that is complementary to the Company’s existing transportation, terminaling, Supply & Trading and environmental services businesses. Direct Midstream’s oil recovery, reclamation and waste-management capabilities also align with Vivakor’s Remediation Processing Center (“RPC”) strategy of recovering reusable hydrocarbons from oilfield waste streams.

“We believe Direct Midstream represents a compelling opportunity to expand Vivakor’s infrastructure footprint in the Permian Basin and add significant produced water and waste-management capabilities to our platform,” said James Ballengee, Chairman, President and Chief Executive Officer of Vivakor. “Direct’s disposal, water management and oil reclamation capabilities are highly complementary to our existing businesses and our broader strategy of building an integrated energy infrastructure and environmental services platform.”

“We are excited about the opportunity to work with Vivakor and explore combining Direct Midstream’s Permian Basin infrastructure and operating expertise with Vivakor’s broader energy platform,” said Chris Early, President and Chief Executive Officer of Direct Midstream. “We believe our integrated approach to water management, disposal and oilfield waste services provides a strong foundation for continued growth, and that a combination with Vivakor could provide additional resources and opportunities to expand our platform.”

The IOI is non-binding, except for certain specified provisions, and the proposed transaction remains subject to further negotiations, due diligence, execution of definitive agreements and satisfaction of applicable closing conditions. There can be no assurance that a definitive agreement will be executed or that the proposed transaction will be completed.

About Direct Midstream, LLC

Direct Midstream LLC is a Midland, Texas-based water midstream company providing produced water infrastructure and oilfield waste management services to oil and gas operators throughout the Permian Basin, with a focus on the Midland Basin. The company provides saltwater disposal, fresh water and brine supply, oilfield waste management, oil reclamation and recovery, and related services.

About Vivakor, Inc.

Vivakor, Inc. is an integrated provider of sustainable energy transportation, storage, reuse, and remediation services. Its corporate mission is to develop, acquire, accumulate, and operate assets, properties, and technologies in the energy sector. Vivakor’s integrated facilities assets provide crude oil, storage, transportation, reuse, and remediation services under long-term contracts. Once operational, Vivakor’s interest in oilfield waste remediation facilities will facilitate the recovery, reuse, and disposal of petroleum byproducts and oilfield waste products.

For more information, please visit our website: www.vivakor.com

Cautionary Statement Regarding Forward-Looking Statements
This news release may contain forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond our control. Actual results and the timing of events may differ materially from the results anticipated in these forward-looking statements. Forward-looking statements may be identified but not limited by the use of the words “anticipates,” “expects,” “intends,” “plans,” “should,” “could,” “would,” “may,” “will,” “believes,” “estimates,” “potential,” or “continue” and variations or similar expressions. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including, but not limited to, the expected transaction and ownership structure, the valuation of the transaction, the likelihood and ability of the parties to successfully and timely consummate planned acquisitions, the risk that any required regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect Vivakor or the expected benefits of the such transaction, our ability to maintain the listing of our securities on The Nasdaq Capital Market, the parties failure to realize the anticipated benefits of pending transactions, disruption and volatility in the global currency, capital, and credit markets, changes in federal, local and foreign governmental regulation, changes in tax laws and liabilities, tariffs, legal, regulatory, political and economic risks, our ability to successfully develop products, rapid change in our markets, changes in demand for our future products, and general economic conditions.

These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor’s filings with the U.S. Securities and Exchange Commission, which factors may be incorporated herein by reference. Actual results, performance or achievements may differ materially, and potentially adversely, from any projections and forward-looking statements and the assumptions on which those forward-looking statements are based. There can be no assurance that the data contained herein is reflective of future performance to any degree. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance as projected financial information and other information are based on estimates and assumptions that are inherently subject to various significant risks, uncertainties and other factors, many of which are beyond our control. All information set forth herein speaks only as of the date hereof in the case of information about Vivakor or the date of such information in the case of information from persons other than Vivakor, and we disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this communication. Forecasts and estimates regarding the industries and markets are based on sources we believe to be reliable; however, there can be no assurance these forecasts and estimates will prove accurate in whole or in part.

Investor Contact:
P:469-480-7175
info@vivakor.com

MEXICO CITY, Oct. 06, 2026 (GLOBE NEWSWIRE) — Grupo Aeroméxico S.A.B. de C.V. (NYSE: AERO & BMV: AERO, “Aeroméxico”) reports its September 2026 operational results.

Grupo Aeroméxico’s total capacity, measured in available seat miles (ASMs), increased 3.4% year-over-year, while demand, measured in revenue passenger miles (RPMs), increased 3.6%.

Aeroméxico’s September load factor was 87.1%, an increase of 0.1 p.p. compared with September 2025. During the month, Aeroméxico transported 1 million and 853 thousand passengers.

Andrés Conesa, Chief Executive Officer stated: “Our September traffic results reflect the strength of our network and the disciplined execution of our strategy to align capacity with demand. Our continued shift toward key international markets, together with disciplined capacity allocation, supported overall demand growth and the strong performance of our international operations while maintaining healthy load factors, despite the typical seasonal moderation in demand following the peak summer travel period. These results reinforce our confidence in the resilience of demand as we move into the final quarter of the year. While higher jet fuel prices continue to create a more challenging cost environment than anticipated, we remain focused on executing our commercial and operational initiatives to optimize our capacity deployment, capture demand opportunities, and support the long-term profitability of the business.”

		September						Cumulative to September
		2026		2025		Var.		2026		2025		Var.
Passengers	Domestic	1,226		1,276		-3.9%		11,662		12,134		-3.9%
(itinerary + charter, thousands)	International	627		617		1.8%		6,304		6,285		0.3%
	Total	1,853		1,892		-2.1%		17,966		18,419		-2.5%
ASMs	Domestic	802		830		-3.4%		7,797		8,041		-3.0%
(itinerary + charter, millions)	International	2,090		1,966		6.3%		19,451		19,013		2.3%
	Total	2,892		2,796		3.4%		27,248		27,054		0.7%
RPMs	Domestic	689		715		-3.7%		6,598		6,851		-3.7%
(itinerary + charter, millions)	International	1,830		1,716		6.6%		16,804		16,267		3.3%
	Total	2,518		2,431		3.6%		23,403		23,119		1.2%
Load Factor	Domestic	85.9%		86.1%		-0.3 p.p.		84.6%		85.2%		-0.6 p.p.
(itinerary, %)	International	87.6%		87.3%		0.2 p.p.		86.4%		85.6%		0.9 p.p.
	Total	87.1%		87.0%		0.1 p.p.		85.9%		85.5%		0.5 p.p.

Figures may not sum to total due to rounding.

The information included within this report has not been audited and does not provide information on the Company’s future performance. Aeromexico’s future performance depends on many factors and it cannot be inferred that any period’s performance or its year-over-year comparison will be an indicator of similar future performance.

Glossary:

• “RPMs” Revenue Passenger Miles represent one revenue-passenger transported one mile. This includes itinerary and charter flights. The total RPMs equals the number of revenue-passengers transported multiplied by the total distance flown.
• “ASMs” Available Seat Miles represent the number of available seats multiplied by the distance flown. This metric is an indicator of the airline’s capacity. It equals one seat offered for one mile, whether the seat is used.
• “Load Factor” equals the number of passengers transported as a percentage of the number of seats offered. It is a measure of the airline’s capacity utilization. This metric considers the total passengers transported and total seats available in itinerary flights only.
• “Passengers” refers to the total number of passengers transported by the airline.

This press release contains certain forward-looking statements that reflect the current views and/or expectations of the Company and its management with respect to its performance, business and future events. We use words such as “believe,” “anticipate,” “plan,” “expect,”, “intend,” “target,” “estimate,” “project,” “predict,” “forecast,” “guideline,” “should” and other similar expressions to identify forward-looking statements, but they are not the only way we identify such statements. Such statements are subject to a number of risks, uncertainties and assumptions. We caution you that a number of important factors could cause actual results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in this release. The Company is under no obligation and expressly disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

About Grupo Aeroméxico
Grupo Aeroméxico, S.A.B. de C.V., is a holding company whose subsidiaries are engaged in commercial aviation in Mexico and in the promotion of passenger loyalty programs. Aeroméxico, Mexico’s global airline, operates primarily out of Terminal 2 of the Mexico City International Airport. Its destination network extends across Mexico, the United States, Canada, Central America, South America, Asia, and Europe. Aeroméxico’s current operating fleet includes Boeing 787 and 737 aircraft, as well as Embraer 190. Aeroméxico is a founding member of SkyTeam, an alliance celebrating 25 years and offering connectivity across more than 145 countries through its 18 partner airlines.

www.aeromexico.com
www.skyteam.com

contact information:
aminvestorrelations@aeromexico.com